Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Apr;126(4):870-9.
doi: 10.1002/lary.25726. Epub 2015 Oct 20.

Natural history and management of Fanconi anemia patients with head and neck cancer: A 10-year follow-up

Affiliations

Natural history and management of Fanconi anemia patients with head and neck cancer: A 10-year follow-up

David I Kutler et al. Laryngoscope. 2016 Apr.

Abstract

Objectives/hypothesis: To describe the management and outcomes of Fanconi anemia (FA) patients with head and neck squamous cell carcinoma.

Study design: Cohort study.

Methods: Demographic information, prognostic factors, therapeutic management, and survival outcomes for FA patients enrolled in the International Fanconi Anemia Registry who developed head and neck squamous cell carcinoma (HNSCC) were analyzed.

Results: Thirty-five FA patients were diagnosed with HNSCC at a mean age of 32 years. The most common site of primary cancer was the oral cavity (26 of 35, 74%). Thirty patients underwent surgical resection of the cancer. Sixteen patients received radiation therapy with an average radiation dose of 5,050 cGy. The most common toxicities were high-grade mucositis (9 of 16, 56%), hematologic abnormalities (8 of 16, 50%), and dysphagia (8 of 16, 50%). Three patients received conventional chemotherapy and had significant complications, whereas three patients who received targeted chemotherapy with cetuximab had fewer toxicities. The 5-year overall survival rate was 39%, with a cause-specific survival rate of 47%.

Conclusions: Fanconi anemia patients have a high risk of developing aggressive HNSCC at an early age. Fanconi anemia patients can tolerate complex ablative and reconstructive surgeries, but careful postoperative care is required to reduce morbidity. The treatment of FA-associated HNSCC is difficult secondary to the poor tolerance of radiation and chemotherapy. However, radiation should be used for high-risk cancers due to the poor survival in these patients.

Level of evidence: 4.

Keywords: Fanconi anemia; head and neck; squamous cell carcinoma.

PubMed Disclaimer

Conflict of interest statement

This manuscript is a Triological Society thesis paper.

Conflicts of Interest: None to report.

Figures

Figure 1
Figure 1
Kaplan-Meier survival curves for Disease-Free Survival (A) and Overall Survival (B) for FA patients with HNSCC
Figure 1
Figure 1
Kaplan-Meier survival curves for Disease-Free Survival (A) and Overall Survival (B) for FA patients with HNSCC

Comment in

References

    1. Auerbach ADBM, Jeonje H. The Metabolic and Molecular Bases of Inherited Disease. New York, NY: McGraw-Hill; 2001.
    1. Giampietro PF, Adler-Brecher B, Verlander PC, Pavlakis SG, Davis JG, Auerbach AD. The need for more accurate and timely diagnosis in Fanconi anemia: a report from the International Fanconi Anemia Registry. Pediatrics. 1993;91:1116–1120. - PubMed
    1. Rickman KA, Lach FP, Abhyankar A, et al. Deficiency of UBE2T, the E2 Ubiquitin Ligase Necessary for FANCD2 and FANCI Ubiquitination, Causes FA-T Subtype of Fanconi Anemia. Cell reports. 2015;12:35–41. - PMC - PubMed
    1. Kottemann MC, Smogorzewska A. Fanconi anaemia and the repair of Watson and Crick DNA crosslinks. Nature. 2013;493:356–363. - PMC - PubMed
    1. Wang AT, Smogorzewska A. SnapShot: Fanconi anemia and associated proteins. Cell. 2015;160:354–354. e351. - PubMed

Publication types